Original Research

Published on 10 Aug 2022

Lutetium background radiation in total-body PET—A simulation study on opportunities and challenges in PET attenuation correction

in PET and SPECT

Negar Omidvari
Li Cheng
Edwin K. Leung
Yasser G. Abdelhafez
Ramsey D. Badawi
Tianyu Ma
Jinyi Qi
Simon R. Cherry

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.963067

3,586 views
10 citations

Mini Review

Published on 09 Aug 2022

Preclinical antibody-PET imaging of PD-L1

in PET and SPECT

Emma L. Brown
Rachel A. DeWeerd
Abbey Zidel
Patricia M. R. Pereira

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.953202

1,416 views
2 citations

Opinion

Published on 28 Jul 2022

Reconstruction-free positron emission imaging: Fact or fiction?

in PET and SPECT

Georg Schramm

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.936091

1,483 views
3 citations

Original Research

Published on 22 Jul 2022

ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization

in Radionuclide Therapy

Fabrizia Gelardi
Marcello Rodari
Cristiano Pini
Roberta Zanca
Alessia Artesani
Giovanni Tosi
Arturo Chiti
Martina Sollini

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.934446

1,250 views

Editorial

Published on 15 Jul 2022

Editorial: F-18 FDG PET/CT Imaging: Normal Variants, Pitfalls and Artifacts

in PET and SPECT

Jasna M. Mihailovic
Ronan P. Killeen

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.965615

713 views

Mini Review

Published on 13 Jul 2022

Clinical Relevance of Nuclear Magnetic Resonance LipoProfile

in Radiopharmacy and Radiochemistry

Emmanuel U. Emeasoba
Emeka Ibeson
Ifeanyi Nwosu
Nadine Montemarano
Jacob Shani
Vijay S. Shetty

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.960522

17,759 views
5 citations

Original Research

Published on 06 Jul 2022

Myocardial Blood Flow and Flow Reserve in Patients With Acute Myocardial Infarction and Obstructive and Non-Obstructive Coronary Arteries: CZT SPECT Study

in PET and SPECT

Konstantin V. Zavadovsky
Darya A. Vorobyeva
Olga V. Mochula
Andrew V. Mochula
Alina N. Maltseva
Andrew E. Bayev
Marina O. Gulya
Alessia Gimelli
Vyacheslav V. Ryabov

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.935539

1,469 views
5 citations

Original Research

Published on 29 Jun 2022

DOTA Conjugate of Bisphosphonate and PSMA-Inhibitor: A Promising Combination for Therapy of Prostate Cancer Related Bone Metastases

in Radiopharmacy and Radiochemistry

Tilmann Grus
Hanane Lahnif
Nicole Bausbacher
Matthias Miederer
Frank Rösch

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.892147

2,138 views
5 citations

Original Research

Published on 10 May 2022

Squaric Acid Bisphposphonates for Theranostics of Bone Metastasis – the Easy DOTA-Zoledronate

in Radiopharmacy and Radiochemistry

Lukas Greifenstein
Nils Engelbogen
Domokos Máthé
Tilmann Grus
Frank Rösch
Ralf Bergmann

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.870910

1,156 views
1 citation

Perspective

Published on 03 May 2022

An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer

in Radionuclide Therapy

Bastiaan M. Privé
Constantijn H. J. Muselaers
Inge M. van Oort
Marcel J. R. Janssen
Steffie M. B. Peters
Willemijn A. M. van Gemert
Maike J. M. Uijen
Melline M. G. Schilham
J. P. Michiel Sedelaar
Harm Westdorp

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.863101

3,681 views
5 citations

Editorial

Published on 25 Apr 2022

Editorial: Molecular Imaging in Multiple Myeloma: An Update and Future Perspectives

in PET and SPECT

Antonia Dimitrakopoulou-Strauss
Christos Sachpekidis
Constantin Lapa

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.904502

709 views

Original Research

Published on 14 Apr 2022

Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends

in Radiopharmacy and Radiochemistry

Claus Zippel
Johannes Ermert
Marianne Patt
Franz Josef Gildehaus
Tobias L. Ross
Gerald Reischl
Torsten Kuwert
Christoph Solbach
Bernd Neumaier
Oliver Kiss

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.850414

9,707 views
3 citations

Original Research

Published on 07 Apr 2022

Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma

in PET and SPECT

Vincent Rebière
Meriem Maajem
Ronan Le Calloch
Leela Raj
Anne-Sophie Le Bris
Mohamed Malou
François Salmon
Isabelle Quintin-Roué
Adrian Tempescul
David Bourhis

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.829138

1,689 views
1 citation

Review

Published on 25 Mar 2022

The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers

in Radiopharmacy and Radiochemistry

E. Johanna L. Stéen
Danielle J. Vugts
Albert D. Windhorst

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.853475

4,585 views
16 citations

Review

Published on 21 Mar 2022

18F-FDG PET/CT Imaging: Normal Variants, Pitfalls, and Artifacts Musculoskeletal, Infection, and Inflammation

in PET and SPECT

Olwethu Mbakaza
Mboyo-Di-Tamba Willy Vangu

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.847810

8,044 views
2 citations

Case Report

Published on 15 Mar 2022

Anti-thyroglobulin Antibodies as a Possible Risk Factor for Graves' Disease After Radioiodine Treatment for Toxic Nodular Goiter: Case Report

in Radionuclide Therapy

Nathalie Rouiller
Marie Nicod Lalonde
Gerasimos P. Sykiotis

Frontiers in Nuclear Medicine

doi 10.3389/fnume.2022.858062

1,807 views
1 citation

Navigation group

Articles

Lutetium background radiation in total-body PET—A simulation study on opportunities and challenges in PET attenuation correction

Preclinical antibody-PET imaging of PD-L1

Reconstruction-free positron emission imaging: Fact or fiction?

ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization

Editorial: F-18 FDG PET/CT Imaging: Normal Variants, Pitfalls and Artifacts

Clinical Relevance of Nuclear Magnetic Resonance LipoProfile

Myocardial Blood Flow and Flow Reserve in Patients With Acute Myocardial Infarction and Obstructive and Non-Obstructive Coronary Arteries: CZT SPECT Study

DOTA Conjugate of Bisphosphonate and PSMA-Inhibitor: A Promising Combination for Therapy of Prostate Cancer Related Bone Metastases

Squaric Acid Bisphposphonates for Theranostics of Bone Metastasis – the Easy DOTA-Zoledronate

An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hormone-Sensitive Prostate Cancer

Editorial: Molecular Imaging in Multiple Myeloma: An Update and Future Perspectives

Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and Trends

Ki67 Immunohistochemical Expression Level ≥70%, Bulky Presentation ≥7.5 cm, Meningeal Lymphomatosis, and Interim PET ΔSUVmax After 4 Treatment Cycles <71% as Parts of a Practical Scoring System to Predict Progression-Free Survival and Overall Survival in Diffuse Large B-Cell Lymphoma

The Application of in silico Methods for Prediction of Blood-Brain Barrier Permeability of Small Molecule PET Tracers

18F-FDG PET/CT Imaging: Normal Variants, Pitfalls, and Artifacts Musculoskeletal, Infection, and Inflammation

Anti-thyroglobulin Antibodies as a Possible Risk Factor for Graves' Disease After Radioiodine Treatment for Toxic Nodular Goiter: Case Report